NeurologyLive® Friday 5 — July 14, 2023

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 14, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Episode 93: Caring for Women With Parkinson Disease

In episode 93 of the Mind Moments Podcast, Jill Farmer, DO, MPH, an assistant professor of neurology and director of the Parkinson’s Disease & Movement Disorder Program at Global Neurosciences Institute, spoke with us about the current landscape of care for women with Parkinson disease (PD), how the approach to their care can differ from men, the major gaps around education and treatment for these women, and much more.

Episode 93: Caring for Women With Parkinson Disease

2: MEDCast: Pregnancy and Family Planning Considerations When Treating Patients With Multiple Sclerosis

In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.

Pregnancy and Family Planning Considerations When Treating Patients With Multiple Sclerosis

3: NeuroVoices: Crystal Proud, MD, on Improving SMA Outcomes Through a Combination Approach

In the latest edition of our in-depth Q&A series, the director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters in Norfolk, Virginia, provided perspective on the phase 4 RESPOND study assessing nusinersen in individuals with SMA who already received gene therapy.

NeuroVoices: Crystal Proud, MD, on Improving SMA Outcomes Through a Combination Approach

4: Efforts Needed to Reach Underserved Communities, Advance Pain Medicine Research: Burel Goodin, PhD

The professor of anesthesiology at Washington University in St. Louis discussed the reasons behind his presentation at the 2023 AHS Annual Meeting on engaging underserved populations in pain medicine research. [WATCH TIME: 3 minutes]

Efforts Needed to Reach Underserved Communities, Advance Pain Medicine Research: Burel Goodin, PhD

5: Lecanemab’s Impact on Care and Diagnosis and the Future of Alzheimer Disease Treatment

Howard Fillit, MD, the cofounder and chief science officer of the Alzheimer's Drug Discovery Foundation, shared his reactions to the recent approval of lecanemab and how it opens doors for future drug development in Alzheimer disease.

Lecanemab’s Impact on Care and Diagnosis and the Future of Alzheimer Disease Treatment
Related Videos
Ro'ee Gilron, PhD
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.